EBITDA for Elevance Health (ELV)
According to Elevance Health's latest reported financial statements, the company's current EBITDA (TTM) is $8.92B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$8.92B
YoY change
-7.9%
5Y CAGR
+3.4%
Peak year (2023)
$10.49B
Cumulative EBITDA
$151.65B
EBITDA history chart for Elevance Health (ELV) from 1998 to 2025
EBITDA history table for Elevance Health (ELV) from 1998 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $9.66B | -7.9% | ||
| 2024 | $10.48B | -0.1% | ||
| 2023 | $10.49B | +3.6% | ||
| 2022 | $10.13B | +1.0% | ||
| 2021 | $10.03B | +22.6% | ||
| 2020 | $8.18B | +4.0% | ||
| 2019 | $7.86B | +13.1% | ||
| 2018 | $6.95B | +24.3% | ||
| 2017 | $5.59B | -9.6% | ||
| 2016 | $6.19B | -0.0% | ||
| 2015 | $6.19B | +6.4% | ||
| 2014 | $5.82B | +8.7% | ||
| 2013 | $5.35B | +4.7% | ||
| 2012 | $5.11B | +1.7% | ||
| 2011 | $5.03B | -6.5% | ||
| 2010 | $5.37B | -36.1% | ||
| 2009 | $8.40B | +100.9% | ||
| 2008 | $4.18B | -33.4% | ||
| 2007 | $6.28B | +6.3% | ||
| 2006 | $5.91B | +43.6% | ||
| 2005 | $4.12B | +122.0% | ||
| 2004 | $1.85B | +16.3% | ||
| 2003 | $1.60B | +524.4% | ||
| 2002 | $255.50M | -58.5% | ||
| 2001 | $616.30M | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — |
EBITDA values are taken from Elevance Health's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Elevance Health (ELV) EBITDA totalled $9.66B – declined 7.9% year-over-year.
Through 2020–2025 (5 years), Elevance Health EBITDA delivered a +3.4% annualised rate; with the latest reading among the more recent periods of the dataset.
Elevance Health EBITDA declined from $10.49B in 2023 to $9.66B in 2025, a 7.9% drawdown.
2023 marks the peak EBITDA at $10.49B, with the historical low of $0 recorded in 1998.
Elevance Health (ELV) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.
Elevance Health EBITDA by Year
Elevance Health EBITDA 2025: $9.66B
Elevance Health EBITDA in 2025 was $9.66B, declined 7.9% below 2024.
Elevance Health EBITDA 2024: $10.48B
Elevance Health EBITDA in 2024 was $10.48B, edged down 0.1% below 2023.
Elevance Health EBITDA 2023: $10.49B
Elevance Health EBITDA in 2023 was $10.49B, edged up 3.6% from 2022. This figure represents the highest annual value in the available history.
Elevance Health EBITDA 2022: $10.13B
Elevance Health EBITDA in 2022 was $10.13B, edged up 1.0% from 2021.
Elevance Health EBITDA 2021: $10.03B
Elevance Health EBITDA in 2021 was $10.03B.
See more financial history for Elevance Health (ELV).
Sector peers — EBITDA
Companies in the same sector as Elevance Health, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Elevance Health's EBITDA?
- Latest reported EBITDA for Elevance Health (ELV) is $8.92B (period ending March 31, 2026).
How has Elevance Health EBITDA changed year-over-year?
- Elevance Health (ELV) EBITDA changed -7.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Elevance Health EBITDA?
- Elevance Health (ELV) EBITDA compound annual growth rate is +3.4% over the most recent 5 years available.
When did Elevance Health EBITDA hit its highest annual value?
- Elevance Health EBITDA reached its highest annual value of $10.49B in 2023.
What was Elevance Health EBITDA in 2024?
- Elevance Health (ELV) EBITDA in 2024 was $10.48B.
What was Elevance Health EBITDA in 2025?
- Elevance Health (ELV) EBITDA in 2025 was $9.66B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ELV Overview
Company profile, financial tools, and key metrics
ELV Revenue Counter
Earns $6,355 every second. See per minute, hour, and day.
ELV Earnings Counter
Earns $166.25 per second net profit. See per minute, hour, and day.
ELV Economic Scale
Exceeds Ukraine's GDP. Compare with world economies.
ELV What If Invested
What if you had invested $1,000? See historical returns from any date.
ELV How It Makes Money
Discover visual breakdown of $200.41B in revenue — where it comes from and where it goes.
ELV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ELV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ELV Daily Price Character
Steady · 51.8% historical win rate (green days). Streaks & record days.
ELV Buybacks
4.41% TTM buyback yield. Shareholder yield & SBC comparison.
ELV Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
ELV Dividend Profile
Yield: 1.82%. Safety: 7/8. See full history.
ELV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ELV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.